(Total Views: 108)
Posted On: 06/27/2018 10:23:36 AM
Post# of 5410
$BIEI / $BIEID -
Premier Biomedical, Inc. Effects Reverse Split
Jackson Center, PA, June 27, 2018 — Premier Biomedical, Inc. (OTC: “BIEI“) a research based publicly traded biomedical company announced that FINRA has approved a corporate action to effect a reverse split on a 250 to 1 share basis. The effects of this action will increase the price of a share of common stock from $0.002 to approximately $0.50. The company announced its intentions to initiate a reverse stock split back in April of this year to facilitate trading at major stock brokers and dealers. For More Information: http://www.thestreetnow.com/spotlight/biei/
Premier Biomedical, Inc. Effects Reverse Split
Jackson Center, PA, June 27, 2018 — Premier Biomedical, Inc. (OTC: “BIEI“) a research based publicly traded biomedical company announced that FINRA has approved a corporate action to effect a reverse split on a 250 to 1 share basis. The effects of this action will increase the price of a share of common stock from $0.002 to approximately $0.50. The company announced its intentions to initiate a reverse stock split back in April of this year to facilitate trading at major stock brokers and dealers. For More Information: http://www.thestreetnow.com/spotlight/biei/
(0)
(0)
